Qiming Venture Partners portfolio Transwarp successfully lists on STAR Market
Retrieved on:
Tuesday, October 18, 2022
Venus, CanSino Biologics, Qiming Venture Partners, Health care, Government, Transport, Growth, Technology, Partner, NYSE, NASDAQ, HKEX, IPO, Shanghai Stock Exchange, Shenzhen Stock Exchange, RMB, San Francisco Bay Area, Software, Initial public offering, STAR, Industry, Big data, Information technology, CEO, UBtech Robotics, Gan, T&C, Mining, Bank, Security (finance), Warp drive
SHANGHAI, Oct. 17, 2022 /PRNewswire/ -- Transwarp, a Qiming Venture Partners portfolio company and China's leading software developer of enterprise big data infrastructure, successfully lists on the STAR board of Shanghai Stock Exchange today.
Key Points:
- SHANGHAI, Oct. 17, 2022 /PRNewswire/ -- Transwarp, a Qiming Venture Partners portfolio company and China's leading software developer of enterprise big data infrastructure, successfully lists on the STAR board of Shanghai Stock Exchange today.
- Transwarp's successful IPO is also the 7th IPO for Qiming Venture Partners since the beginning of 2022.
- Kuantai Yeh, Partner of Qiming Venture Partners, said, "I am glad to witness another milestone moment of Transwarp.
- Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.4 billion in capital raised.